The BBC speaks with 23andMe's Linda Avey and Anne Wojcicki about their company and their motivation. "The reason we started this company is that we really dramatically wanted to change healthcare," Wojcicki tells the BBC. Avey adds that they think that if people know their genetic information, they will take better care of themselves. The BBC also mentions that FDA is "warming to personal gene services," though the public still has some concerns.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.